Generic competition · all medicines · read 12 November 2026
Is there a generic of Testosterone Undecanoate, and who makes it?
Testosterone Undecanoate appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed. 2 groups have a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. This is the Orange Book's listing, not a forecast.
Method designed and maintained by Vincent Wesley Couey (ORCID 0009-0005-6869-308X). Data compiled automatically from the Orange Book data files, downloaded 12 November 2026. How these pages are made
- Testosterone Undecanoate appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed.
- 2 groups have a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
- Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.
Capsule, Oral
Brand listed, no generic listed as marketed
Brand listed as marketed: Jatenzo, Kyzatrex and Tlando. No generic is listed as marketed.
Patents and exclusivities still listed
- 6 January 2027Patent 11331325
- 8 January 2029Patent 11304960 drug product
- 8 January 2029Patent 8865695
- 8 January 2029Patent 8778922 drug product
- 29 March 2029Patent 8241664 drug product
- 12 April 2030Patent 10543219
- 12 April 2030Patent 11179403
- 12 April 2030Patent 11426416
23 more patents are listed.
Injectable, Intramuscular
Brand listed, no generic listed as marketed
Brand listed as marketed: Aveed. No generic is listed as marketed.
Patents and exclusivities still listed
- 14 March 2027Patent 7718640 drug product
- 8 May 2027Patent 8338395
US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.
What do pharmacies pay for Testosterone Undecanoate?
The CMS NADAC survey tracks what pharmacies pay to acquire Testosterone Undecanoate: 12 products with year-end prices from 2014 to 2026. See the acquisition cost history on RxGrab. It is a pharmacy cost, not a retail price, and this page does not say how it relates to the number of makers listed above.
Where can you go from this result?
Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.